title: FOLFOX2 regimen in the treatment of advanced colorectal cancer: a comparison between elderly and young patients.
authors.forename: M
authors.initials: M
authors.lastname: Berretta
authors.forename: A
authors.initials: A
authors.lastname: Bearz
authors.forename: S
authors.initials: S
authors.lastname: Frustaci
authors.forename: A
authors.initials: A
authors.lastname: Buonadonna
authors.forename: N
authors.initials: N
authors.lastname: La Mura
authors.forename: M
authors.initials: M
authors.lastname: Malaguarnera
authors.forename: A
authors.initials: A
authors.lastname: Fulvi
authors.forename: I
authors.initials: I
authors.lastname: Shehu
authors.forename: U
authors.initials: U
authors.lastname: Tirelli
mesh_terms: D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000473:pathology; D005240:Feasibility Studies; D005472:Fluorouracil / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D002955:Leucovorin / Q000009:adverse effects / Q000627:therapeutic use; D008875:Middle Aged; D009944:Organoplatinum Compounds / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D009944:Organoplatinum Compounds; D002955:Leucovorin; D005472:Fluorouracil